Loading…
Aarti Pharmalabs (AARTIPHARM)₹921.40−0.89%Pharmaceuticals
At the end of the Sep 2026 quarter, Aarti Pharmalabs' shareholders were: promoters 39.62%, FIIs 8.18%, DIIs 8.45%, government 0.01%, public 43.74%. Promoter holding is down 3.20 percentage points from 42.82% a quarter earlier. FII holding is up 0.14 percentage points from 8.04% a year earlier. 11.09% of promoter shares were pledged. It had 1,74,308 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 46.42% | 46.42% | 46.42% | 46.06% | 44.61% | 44.25% | 43.68% | 42.84% | 43.06% | 43.04% | 42.82% | 39.62% |
| FIIs | 8.19% | 8.35% | 7.09% | 7.40% | 8.66% | 7.38% | 7.36% | 8.04% | 7.71% | 8.41% | 8.19% | 8.18% |
| DIIs | 9.96% | 10.02% | 11.52% | 11.40% | 10.41% | 7.58% | 7.85% | 7.00% | 7.71% | 7.45% | 7.27% | 8.45% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 35.42% | 35.20% | 34.96% | 35.13% | 36.31% | 40.78% | 41.10% | 42.11% | 41.51% | 41.09% | 41.71% | 43.74% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 11.09% |
| Number of shareholders | 2,15,769 | 2,04,097 | 1,88,989 | 1,85,413 | 1,85,088 | 1,96,290 | 1,87,016 | 1,90,631 | 1,84,466 | 1,79,351 | 1,76,484 | 1,74,308 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Life Insurance Corporation Of India | DII | 4.74% | −0.56 |
| Rashesh Chandrakant Gogri | Promoter | 4.26% | 0.00 |
| Jaya Chandrakant Gogri | Promoter | 3.56% | 0.00 |
| Anushakti Enterprise Private Limited | Promoter | 3.31% | 0.00 |
| Hetal Gogri Gala | Promoter | 3.14% | 0.00 |
| LABDHI BUSINESS TRUST(Saswat Trusteeship Private Limited) | Promoter | 3.14% | 0.00 |
| Mirik Rajendra Gogri | Promoter | 3.06% | 0.00 |
| Renil Rajendra Gogri | Promoter | 2.82% | 0.00 |
| Sarla Shantilal Shah | Promoter | 2.72% | 0.00 |
| MANOMAYA BUSINESS TRUST(Alabhya Trusteeship Private Limited) | Promoter | 1.43% | 0.00 |
| Nehal Garewal | Promoter | 1.23% | 0.00 |
| Rajendra Vallabhaji Gogri | Promoter | 1.13% | −0.43 |
| Nishant Pradip Shah | Public | 1.11% | 0.00 |
| Heena Family Private Trust(Barclays Wealth Trustees India Private Limited) | Promoter | 0.92% | 0.00 |
| Bhavna Family Private Trust(Barclays Wealth Trustees India Pvt Ltd) | Promoter | 0.89% | 0.00 |
| Alchemie Financial Services Limited | Promoter | 0.75% | 0.00 |
| Nikhil Parimal Desai | Promoter | 0.73% | −0.01 |
| Aarnav Rashesh Gogri | Promoter | 0.61% | 0.00 |
| Aashay Rashesh Gogri | Promoter | 0.61% | 0.00 |
| Manisha Rashesh Gogri | Promoter | 0.61% | 0.00 |
| Safechem Enterprises Private Limited | Promoter | 0.40% | −0.30 |
| Parimal Hasmukhlal Desai | Promoter | 0.39% | 0.00 |
| Ratanben Premji Gogri | Promoter | 0.38% | 0.00 |
| Gogri Finserv Pvt. Ltd. | Promoter | 0.37% | 0.00 |
| Heena Bhatia | Promoter | 0.36% | 0.00 |
Promoters held 39.62% of Aarti Pharmalabs at the end of the Sep 2026 quarter, down 3.22 percentage points from 42.84% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 8.18% (down 0.01 percentage points from 8.19% a quarter earlier) and domestic institutions (DIIs) held 8.45% (up 1.18 percentage points from 7.27% a quarter earlier).
Yes. 11.09% of promoter shares were pledged at the end of the Sep 2026 quarter.
Aarti Pharmalabs had 1,74,308 shareholders at the end of the Sep 2026 quarter, against 1,90,631 a year earlier.
Life Insurance Corporation Of India (DII) held 4.74% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.